pSivida Corp. Stock Nasdaq

Stocks

09/08/16	PSivida : Primary Endpoint Met in pSivida's Utilization Study of New Medidur™ Inserter with Smaller Diameter Needle	PU
14/07/16	PSivida : Investigator-Sponsored Phase 2 Study Results Show pSivida's Medidur® Fully Controlled Uveitis for Two Years with No Recurrence of Disease While Visual Acuity Continued to Improve	PU
02/05/16	PSivida : Medidur for Posterior Uveitis Granted Orphan Drug Designation in Europe	PU
28/09/15	PSivida : Announces NDA for Medidur™ Now Planned Using Six-Month Efficacy Data from Both Phase III Trials; FDA Concurs	BU
14/09/15	PSivida : CEO to Present at Ladenburg Thalmann 2015 Healthcare Conference September 29, 2015	BU

1 day

-0.87%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
PSIVIDA CORP.	-0.87%	-2.40%	-	-	0
WUXI APPTEC CO., LTD.	-0.70%	-4.35%	+56.10%	+86.42%	71.81B
ARGENX SE	+0.45%	-0.82%	+38.81%	+84.19%	60.06B
WUXI BIOLOGICS (CAYMAN) INC.	+0.19%	+0.94%	+36.97%	+21.32%	27.93B
INSMED INCORPORATED	-1.83%	-4.23%	-18.31%	+358.26%	25.7B
BIONTECH SE	-0.74%	-2.50%	+0.25%	-9.48%	24.89B
GENMAB A/S	+0.65%	+1.67%	+26.47%	-7.62%	20.92B
PHARMAESSENTIA CORPORATION	+3.46%	+3.91%	+158.90%	+337.81%	15.04B
EXELIXIS, INC.	+0.08%	+0.33%	+43.80%	+167.00%	14.46B
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.	+3.91%	-4.56%	-2.71%	+506.41%	13.87B
Average	+0.46%	-0.92%	+37.81%	+171.59%	30.52B
Weighted average by Cap.	+0.14%	-1.74%	+38.11%	+128.11%